Skip to content
Lower risk Medical device recall · FDA · Published March 29, 2018

Stryker Sustainability Solutions recalls Coronary Sinus Uni-Directional Diagnostic EP

Stryker Sustainability Solutions recalls two specific Coronary Sinus Uni-Directional Diagnostic EP Catheter models (D135303/D135304) due to failing non-thrombogenic specifications in testing. The catheters are used for cardiac electrophysiology mapping.

Take action

Contact the company

Recalling firmStryker Sustainability Solutions1810 W Drake Dr · Tempe, AZ 85283-4327
✎ GovInfoNow plain-language explainer

What happened, in plain English

Stryker Sustainability Solutions is recalling two specific models of Coronary Sinus Uni-Directional Diagnostic EP Catheters (D135303 and D135304) because lab tests showed they don't meet the required non-thrombogenic standard. This means they could potentially cause blood clots in normal use during cardiac procedures. Read more at govinfonow.com/recall/71582-stryker-sustainability-solutions-recalls-coronary-sinus-uni-directional-diagnostic-ep.

Source Summary by GovInfoNow · govinfonow.com/recall/71582-stryker-sustainability-solutions-recalls-coronary-sinus-uni-directional-diagnostic-ep · Updated August 21, 2026 · FDA enforcement record: FDA #Z-2426-2018

Cite this page

“Stryker Sustainability Solutions recalls Coronary Sinus Uni-Directional Diagnostic EP.” GovInfoNow, updated August 21, 2026. https://govinfonow.com/recall/71582-stryker-sustainability-solutions-recalls-coronary-sinus-uni-directional-diagnostic-ep. Based on FDA recall #Z-2426-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2426-2018%22&limit=1).

Why it’s dangerous

The catheters failed internal testing for non-thrombogenicity, meaning they could potentially cause blood clots during cardiac procedures. However, the hazard is described as a failure to meet specifications rather than a direct risk of injury in normal use.

Who’s affected

Healthcare professionals using these catheters for cardiac electrophysiology procedures are most at risk. Patients who received these catheters during procedures are not directly affected by the recall.

How to tell if you have this one

Check for product catalog numbers D135303 or D135304 on the catheter packaging or label. These are specific models of Coronary Sinus Uni-Directional Diagnostic EP Catheters used for cardiac electrophysiology mapping.

  • Brand
    Stryker Sustainability Solutions
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Catalog Number

    Look for catalog numbers D135303 or D135304 on the catheter packaging or label to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide Distribution - US Nationwide and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2.3 years after the firm started it.

1. Firm started the recall: Mar 29, 201812. FDA classified it Class II: Jul 12, 201823. Published in FDA’s Enforcement Report: Jul 18, 201834. FDA terminated the recall: Jul 28, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2426-2018 (March 29, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2426-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 21, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA